Complicated Urinary Tract Infections - Pipeline Insight, 2021
SKU ID :DEL-19044456 | Published Date: 01-Sep-2021 | No. of pages: 60Description
TOC
Introduction
Executive Summary
Complicated Urinary Tract Infections: Overview
• Causes
• Mechanism of Action
• Signs and Symptoms
• Diagnosis
• Disease Management
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Late Stage Products (Phase III)
• Comparative Analysis
Tebipenem Pivoxil Hydrobromide: Spero Therapeutics
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
• Comparative Analysis
Benapenem: Sihuan Pharmaceutical
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Early stage products (Phase I)
• Comparative Analysis
ETX0282CPDP: Entasis Therapeutics
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
• Comparative Analysis
Complicated Urinary Tract Infections Key Companies
Complicated Urinary Tract Infections Key Products
Complicated Urinary Tract Infections- Unmet Needs
Complicated Urinary Tract Infections- Market Drivers and Barriers
Complicated Urinary Tract Infections- Future Perspectives and Conclusion
Complicated Urinary Tract Infections Analyst Views
Complicated Urinary Tract Infections Key Companies
Appendix
Tables & Figures
Table 1 Total Products for Complicated Urinary Tract Infections
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products
Companies
• Wockhardt
• Spero Therapeutics
• Iterum Therapeutics
• Sihuan Pharmaceuticals
• Entasis Therapeutics
• SuperTrans Medical
• Locus Biosciences
• Venatorx Pharmaceuticals
• MerLion Pharmaceuticals
• Allecra Therapeutics
- PRICE
-
$1500$4500